
The treatment is to protect children under two years of age from respiratory syncytial virus

Hypertension affects more than 1.4 billion people worldwide and many patients remain uncontrolled despite multiple therapies

In 2026, an estimated 22,720 people in the US will be diagnosed with AML

Taken at any time of the day, the oral GLP-1 is the only pill to have no food or water restrictions

Quotient’s somatic genomics platform technology will be used to develop the treatment

The autoimmune disease affects approximately three to five million people globally

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths

The pharma company will invest more than $70bn in the US to boost production and innovation

Cidara’s long-acting viral flu drug showed significant protection in phase 2 results

Merck will take full control of developing MK-8690, an investigational monoclonal antibody candidate

The funding will support late-stage clinical development of the investigational antibody-drug conjugate

Weinreich brings clinical development and venture capital experience to the role